Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

A woman poisoned with thallium was successfully treated with activated charcoal and Prussian blue.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

Hantavirus survivors often face long-term health issues, needing ongoing care.

Many people in Thailand have lingering symptoms after recovering from COVID-19.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Partially bald areas in Indian AGA patients still have hair growth cells, suggesting early treatment is best.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

Dermoscopy helps diagnose folliculotropic mycosis fungoides by identifying specific skin patterns.

Dissecting Cellulitis of the Scalp is more common in young men and often associated with head and neck acne.

Acne keloidalis nuchae is a hair loss condition affecting men of African descent, causing scar-like bumps on the scalp and neck.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Hair loss can cause anxiety and depression, especially in young, single women, and early psychological support is important.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

A rare genetic mutation caused severe symptoms in a 6-year-old girl with mandibuloacral dysplasia type A.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.